- Lobbying
- novartis AND services
Lobbying Arrangements Results for 'Novartis Services'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to coverage and reimbursement of pharmaceuticals. Issues related to coverage and reimbursement of pharmaceuticals |
Novartis Corporation
|
SCULLY ROSKEY AND MISSMAR | |||
Details Healthcare |
Novartis Vaccines and Diagnostics, Inc
|
Trimpa Group LLC | |||
Details H.R.6, 21st Century Cures Act. S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015. H.R.3618, Orphan Drug Fairness Act. P.L.114-113, Consolidated Appropriations Act, 2016. Healthca... |
Novartis Services, Inc.
|
Rampy Northrup LLC | |||
Details REgulatory and legislative advice covering Medicare and Medicaid and other health policy issues. |
Novartis Corporation
|
LAW OFFICES OF FREDERICK H. GRAEFE, PLLC | |||
Details Labor, Health and Human Services, Education and Related Agencies Appropriations Bill, Supplemental Appropriations Bill, Bioterrorism, FDA enforcement, and DoD Appropriations. |
Novartis Vaccines and Diagnostics, Inc.
Manufacturer of vaccines and blood diagnostic products. |
PARRY, ROMANI, DECONCINI & SYMMS | |||
Details Support increased funding for the CDC National Immunization Program (sec 317 program) |
Novartis
|
Cornerstone Government Affairs, LLC | |||
Details Issues related to drug policy, including reimbursement. |
Novartis Corporation
|
ALSTON & BIRD LLP | |||
Details General healthcare, pharmaceutical and Food and Drug Administration (FDA) related issues. S.2041, Promoting Life-Saving New Therapies for Neonates Act of 2015; neonatal drug issues. H.R.3618, Orpha... |
Novartis Services, Inc.
|
Ogilvy Government Relations | |||
Details Track and trace technologies for safe medicines |
NOVARTIS
|
CROWELL & MORING INTERNATIONAL, LTD. | |||
Details Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R. 4872) American Jobs and Closing Tax Loopholes Act of 2010 (H. R. 4213) |
NOVARTIS
|
FOLEY HOAG LLP | |||
Details Medicare reimbursement for laboratory tests. |
Physician Fee Schedule Pathology Payment Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislation, include the Prescription Dr... |
Novartis
|
East End Group, LLC | |||
Details S. 1710, Labor-HHS-Education and related Agencies Appropriations Act, pandemic funding and vaccine issues HR 3043, Labor - HHS-Education and related Agencies appropriations Act, pandemic influenza ... |
Novartis Vaccines and Diagnostics, Inc.
|
in-house lobbying | |||
Details CBO modeling Drug Pricing Fiscal year 2024 Appropriations H.R. 5376, Inflation Reduction Act H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024 Importation Value of Med... |
NOVARTIS
|
in-house lobbying | |||
Details Medicare reimbursement for laboratory tests. Issues concerning regulation of laboratory tests. |
Clinical Laboratory Fee Schedule Reform Coalition
|
MCDERMOTT WILL & EMERY LLP | |||
Details Medicare reimbursement for laboratory tests. Issues concerning regulation of laboratory tests. |
Clinical Laboratory Fee Schedule Reform Coalition
|
McDermott+Consulting LLC | |||
Details Issues related to importation of prescription drugs issues affecting pharmaceutical manufacturers in HR 3590, the Patient Protection and Affordable Care Act issues related to coverage of vaccines i... |
NOVARTIS
|
RICCHETTI INCORPORATED | |||
Details DOJ policy regarding off label communications. |
Medical Information Working Group
|
SIDLEY AUSTIN LLP | |||
Details Health care policy and reform. Medical innovation. Cancer treatments. H.R.2641 - Promoting Life-Saving New Therapies for Neonates Act of 2017. Issues related to drug pricing. S.540 - Mobile Workfor... |
Novartis Services, Inc.
|
PODESTA GROUP, INC. | |||
Details Issues related to congressional vision caucus events and eye health. Issues related to Medicare reimbursement and ASC settings. |
Novartis Corporation
|
THE NICKLES GROUP, LLC | |||
Details Enforcement priorities and policies regarding communications by pharmaceutical and medical device manufacturers about their medical products. |
Medical Information Working Group
|
Ropes & Gray, LLP | |||
Details Implementation of Tax Reform, international tax proposals related to intellectual property. Issues related to Biosimilar Approvals and implementation of biologic price competition and innovation ac... |
NOVARTIS CORPORATION
|
CAPITOL HILL CONSULTING GROUP | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); S. 476 - Maintaining Investments in New Innovation Act. Is... |
Tiber Creek Health Strategies, Inc. (On behalf of Novartis)
|
Tiber Creek Group | |||
Details Supply Chain. 340B Issues. Biologics Price Competition and Innovation Act. Outcomes based contracting/value-based arrangements. Genetically Targeted Therapies. Advanced Research Projects Agency for... |
Novartis, Inc.
|
Todd Strategy Group | |||
Details Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Senio... |
The Biosimilars Forum
|
Thorn Run Partners | |||
Details Medicare reimbursement issues, FDA regulation of biosimilars. |
The Biosimilars Forum
|
HOLLAND & KNIGHT LLP | |||
Details Pharmaceutical distribution and supply chain security. |
Pharmaceutical Distribution Security Alliance (PDSA)
|
Leavitt Partners, LLC | |||
Details Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010 - Funding for domestic vaccine supply, Centers for Disease Control, National Institutes... |
NOVARTIS CORP.
|
PARRY, ROMANI, DECONCINI & SYMMS |